Back to Search
Start Over
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.
- Source :
-
Clinical and translational medicine [Clin Transl Med] 2024 Jun; Vol. 14 (6), pp. e1691. - Publication Year :
- 2024
- Subjects :
- Humans
Proto-Oncogene Proteins c-myc genetics
Proto-Oncogene Proteins c-myc metabolism
Lymphoma drug therapy
Lymphoma genetics
Lymphoma metabolism
Histone Deacetylase Inhibitors pharmacology
Histone Deacetylase Inhibitors therapeutic use
Proto-Oncogene Proteins c-bcl-2 genetics
Proto-Oncogene Proteins c-bcl-2 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2001-1326
- Volume :
- 14
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Clinical and translational medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38812093
- Full Text :
- https://doi.org/10.1002/ctm2.1691